News

Hudson Institute has entered into a Research and Development Alliance Agreement with Invion Limited to provide key scientific assessment of Invion’s cancer treatment technology, Photosoft. The collaboration will initially focus on the treatment of ovarian cancer, with a view to expanding research and development projects into other forms of cancer. Hudson Institute will provide the…  Read more

The inaugural Dr Sue Fowler Scholarship in Ovarian Cancer has been awarded to PhD student, Mrs Nazanin Karimnia to support her research into new ovarian cancer therapies. The scholarship was established in honour of the late Dr Sue Fowler, to support a Hudson Institute PhD student undertaking research into ovarian cancer. There is an urgent…  Read more

Jasmine started experiencing severe period pain as a teenager and endured five years of pain before she was diagnosed with endometriosis. Her journey continues.…  Read more

High doses of glucocorticoids are not effective in preventing life-threatening asthma flare-ups, according to a landmark study published in The New England Journal of Medicine (NEJM). Glucocorticoids are anti-inflammatory medications used in many everyday prescription asthma puffers, such as turbuhalers or accuhalers. Hudson Institute research group head, Professor Phil Bardin was invited by the NEJM…  Read more

‘Invisible illness’ took years of pain and a trip to the emergency ward before diagnosis. It wasn’t until Evelyn’s debilitating symptoms started to impact her daily life that she sought help – but that was only the beginning of her journey.…  Read more

Bianca had the worst case of endometriosis her doctors said they had seen. Yet, she had no pelvic pain and was only diagnosed after experiencing infertility. She now wants to raise awareness so that other women don’t suffer.…  Read more

Early career researchers Dr Stacey Ellery and Ms Aya Mousa have won the MHTP Research Week ECR speed networking event, receiving a $10,000 grant to progress their research idea.…  Read more

Uncovering how abnormal immune cell populations in the womb could be linked to repeat implantation failure and early pregnancy loss is the focus of new research by Dr Ellen Menkhorst. Dr Menkhorst, a Research Scientist in the Embryo Implantation Research Group, has been awarded a $100,000 grant from the Rebecca L. Cooper Foundation to help…  Read more

Scientists at Hudson Institute of Medical Research have identified a family of genes that could more accurately detect stomach cancer in its early stages to help improve survival rates. Stomach or gastric cancer is the third leading cause of cancer death worldwide. It is caused by the abnormal growth of cells in the lining, or…  Read more

Hudson Institute of Medical Research scientists are combining stem cells from the lining of a woman’s own uterus with nanobiomaterials (biodegradable materials engineered on the nanoscale) in a world-first approach to develop safer, more effective treatments for pelvic organ prolapse.…  Read more